BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16686534)

  • 21. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
    González-Avión XC; Mouriño A; Rochel N; Moras D
    J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D
    Szybinski M; Sektas K; Sicinski RR; Plum LA; Frelek J; DeLuca HF
    J Steroid Biochem Mol Biol; 2017 Jul; 171():144-154. PubMed ID: 28285018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationships of 16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs having side chains of different sizes.
    Takaku H; Miyamoto Y; Asami S; Shimazaki M; Yamada S; Yamamoto K; Udagawa N; DeLuca HF; Shimizu M
    Bioorg Med Chem; 2008 Feb; 16(4):1796-815. PubMed ID: 18032055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-desoxy analog of 2MD: synthesis and biological activity of (20S)-25-hydroxy-2-methylene-19-norvitamin D3.
    Sibilska I; Barycka KM; Sicinski RR; Plum LA; Deluca HF
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):51-5. PubMed ID: 20347975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
    Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N
    Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
    Peleg S; Petersen KS; Suh BC; Dolan P; Agoston ES; Kensler TW; Posner GH
    J Med Chem; 2006 Dec; 49(25):7513-7. PubMed ID: 17149880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and Biological Activity of 2-Methylene Analogues of Calcitriol and Related Compounds.
    Sibilska IK; Szybinski M; Sicinski RR; Plum LA; DeLuca HF
    J Med Chem; 2015 Dec; 58(24):9653-62. PubMed ID: 26574921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, conformational analysis, and biological evaluation of 19-nor-vitamin D3 analogues with A-ring modifications.
    Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Gotor V; Ferrero M
    J Med Chem; 2009 Oct; 52(19):6158-62. PubMed ID: 19739672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Removal of the 26-methyl group from 19-nor-1α,25-dihydroxyvitamin D₃ markedly reduces in vivo calcemic activity without altering in vitro VDR binding, HL-60 cell differentiation, and transcription.
    Grzywacz P; Chiellini G; Plum LA; Clagett-Dame M; DeLuca HF
    J Med Chem; 2010 Dec; 53(24):8642-9. PubMed ID: 21105677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New 1alpha,25-dihydroxy-19-norvitamin D3 analogs with a frozen A-ring conformation.
    Glebocka A; Sicinski RR; Plum LA; DeLuca HF
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):46-50. PubMed ID: 20214980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of novel 6-substituted analogs of 1α,25-dihydroxy-19-norvitamin D3.
    Sokolowska K; Sicinski RR; Mouriño A; Plum LA; DeLuca HF
    J Steroid Biochem Mol Biol; 2013 Jul; 136():30-3. PubMed ID: 23116698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, structure, and biological activity of des-side chain analogues of 1α,25-dihydroxyvitamin D3 with substituents at C18.
    Verlinden L; Verstuyf A; Eelen G; Bouillon R; Ordóñez-Morán P; Larriba MJ; Muñoz A; Rochel N; Sato Y; Moras D; Maestro M; Seoane S; Dominguez F; Eduardo-Canosa S; Nicoletti D; Moman E; Mouriño A
    ChemMedChem; 2011 May; 6(5):788-93. PubMed ID: 21520419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remarkable effect of 2[small alpha]-modification on the VDR antagonistic activity of 1small alpha-hydroxyvitamin D3-26,23-lactones.
    Saito N; Matsunaga T; Fujishima T; Anzai M; Saito H; Takenouchi K; Miura D; Ishizuka S; Takayama H; Kittaka A
    Org Biomol Chem; 2003 Dec; 1(24):4396-402. PubMed ID: 14685312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The first locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D3) induce vitamin D receptor transcriptional activity.
    Pérez-García X; Rumbo A; Larriba MJ; Ordóñez P; Muñoz A; Mouriño A
    Org Lett; 2003 Oct; 5(22):4033-6. PubMed ID: 14572242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D₃ analogues with a long side chain at C12 and short C17 side chains.
    Carballa DM; Seoane S; Zacconi F; Pérez X; Rumbo A; Alvarez-Díaz S; Larriba MJ; Pérez-Fernández R; Muñoz A; Maestro M; Mouriño A; Torneiro M
    J Med Chem; 2012 Oct; 55(20):8642-56. PubMed ID: 22989379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activity of 25-hydroxy-2-methylene-vitamin D3 compounds.
    Sibilska I; Sicinski RR; Plum LA; DeLuca HF
    J Steroid Biochem Mol Biol; 2013 Jul; 136():17-22. PubMed ID: 23274116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1alpha,25-dihydroxyvitamin D analogues, diastereomeric at C17 and C20.
    Zhou X; Zhu GD; Van Haver D; Vandewalle M; De Clercq PJ; Verstuyf A; Bouillon R
    J Med Chem; 1999 Sep; 42(18):3539-56. PubMed ID: 10479287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An analog of 1alpha,25-dihydroxy-19-norvitamin D3 with the 1alpha-hydroxy group fixed in the axial position lacks biological activity in vitro.
    Sicinski RR; Glebocka A; Plum LA; DeLuca HF
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):293-7. PubMed ID: 17223547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of 19-norcalcitriol analogs with elongated side chain.
    Brzeminski P; Fabisiak A; Sektas K; Berkowska K; Marcinkowska E; Sicinski RR
    J Steroid Biochem Mol Biol; 2018 Mar; 177():231-234. PubMed ID: 28823515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.
    Nakano Y; Kato Y; Imai K; Ochiai E; Namekawa J; Ishizuka S; Takenouchi K; Tanatani A; Hashimoto Y; Nagasawa K
    J Med Chem; 2006 Apr; 49(8):2398-406. PubMed ID: 16610783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.